T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$1.21B |
| 2 |
RTX Corp
RTX
|
+$1.14B |
| 3 |
PepsiCo
PEP
|
+$1.12B |
| 4 |
ASML
ASML
|
+$817M |
| 5 |
Wynn Resorts
WYNN
|
+$798M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Mastercard
MA
|
+$1.08B |
| 3 |
Qualcomm
QCOM
|
+$972M |
| 4 |
eBay
EBAY
|
+$898M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$748M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.21% |
| 2 | Consumer Discretionary | 13.72% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 12.45% |
| 5 | Technology | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Standex International
SXI
$4B
| $3.24M | ﹤0.01% |
60,500
| – | – |
|
|
TCS
1477
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $3.19M | ﹤0.01% |
6,260
-15,333
| -71% | -$8.44M |
|
1478
Cedar Fair
FUN
$1.69B
| $3.17M | ﹤0.01% |
62,218
-1,700
| -3% | -$87.4K |
|
|
BRLI
1479
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $3.15M | ﹤0.01% |
113,700
-16,800
| -13% | -$440K |
|
1480
Heartland Express
HTLD
$991M
| $3.12M | ﹤0.01% |
137,599
-30
| -0% | -$627 |
|
1481
Crawford & Co Class A
CRD.A
$622M
| $3.11M | ﹤0.01% |
333,430
+173,411
| +108% | +$1.38M |
|
|
CBI
1482
DELISTED
Chicago Bridge & Iron Nv
CBI
| $3.1M | ﹤0.01% |
35,582
+7,666
| +27% | +$623K |
|
1483
Opko Health
OPK
$993M
| $3.09M | ﹤0.01% |
332,000
+20,700
| +7% | +$181K |
|
1484
Murphy USA
MUSA
$10.5B
| $3.08M | ﹤0.01% |
75,755
| – | – |
|
|
FUEL
1485
DELISTED
Rocket Fuel Inc.
FUEL
| $3.06M | ﹤0.01% |
71,383
-66,917
| -48% | -$3.67M |
|
|
RGLS
1486
DELISTED
Regulus Therapeutics
RGLS
| $3.04M | ﹤0.01% |
2,805
-21
| -0.7% | -$23.3K |
|
1487
ONE Gas
OGS
$5.08B
| $3.03M | ﹤0.01% |
+84,292
| New | +$2.9M |
|
|
UTEK
1488
DELISTED
Ultratech Inc.
UTEK
| $3.03M | ﹤0.01% |
103,700
+2,800
| +3% | +$74.7K |
|
|
CTP
1489
DELISTED
CTPARTNERS EXECUTIVE SEARCH INC (DE)
CTP
| $3.02M | ﹤0.01% |
277,416
-38,614
| -12% | -$287K |
|
|
ENDP
1490
DELISTED
Endo International plc
ENDP
| $3.02M | ﹤0.01% |
43,992
+2,773
| +7% | +$197K |
|
1491
Protolabs
PRLB
$2.19B
| $2.98M | ﹤0.01% |
44,000
-24,900
| -36% | -$1.85M |
|
1492
Rio Tinto
RIO
$156B
| $2.9M | ﹤0.01% |
51,890
-1,030,800
| -95% | -$56.2M |
|
1493
Pegasystems
PEGA
$5.35B
| $2.9M | ﹤0.01% |
+328,000
| New | +$3.54M |
|
|
TVRD
1494
Tvardi Therapeutics
TVRD
$23.6M
| $2.9M | ﹤0.01% |
+4,323
| New | +$2.56M |
|
|
FIO
1495
DELISTED
FUSION-IO INC COM
FIO
| $2.86M | ﹤0.01% |
272,100
+8,900
| +3% | +$94.2K |
|
1496
Miller Industries
MLR
$644M
| $2.85M | ﹤0.01% |
146,010
| – | – |
|
1497
Arch Capital
ACGL
$33.7B
| $2.84M | ﹤0.01% |
148,137
-235,983
| -61% | -$4.37M |
|
|
MCEP
1498
DELISTED
Mid-Con Energy Partners, LP
MCEP
| $2.83M | ﹤0.01% |
6,553
+1,869
| +40% | +$857K |
|
1499
SiriusXM
SIRI
$9.52B
| $2.81M | ﹤0.01% |
87,756
+3,636
| +4% | +$129K |
|
1500
Genpact
G
$5.71B
| $2.81M | ﹤0.01% |
161,000
-29,000
| -15% | -$489K |
|
Similar funds
T. Rowe Price Associates's Q1 2014 Portfolio in Review
As of Q1 2014, T. Rowe Price Associates held 2,567 positions worth $445B, up 2% from $436B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q1 2014 filing shows 89 new, 904 increased, 825 reduced and 68 closed positions. Its largest new stake was Liberty Global Class C: 13,695,496 shares worth $451M. The largest sale was Apple, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2014 buy was Liberty Global Class C: 13,695,496 shares worth $451M.
- T. Rowe Price Associates added most to American Airlines Group in Q1 2014, an estimated $1.21B increase.
- T. Rowe Price Associates's biggest Q1 2014 reduction was Apple, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $200M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $445B portfolio in Q1 2014.
- T. Rowe Price Associates opened 89 new positions and closed 68 in Q1 2014.
- T. Rowe Price Associates's portfolio value rose 2% quarter-over-quarter to $445B.
Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.